WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016099146) MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/099146    International Application No.:    PCT/KR2015/013789
Publication Date: 23.06.2016 International Filing Date: 16.12.2015
IPC:
C07C 309/14 (2006.01), A61K 31/18 (2006.01), A61K 31/7004 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01)
Applicants: BYUN, Jonghyun [KR/KR]; (KR)
Inventors: BYUN, Jonghyun; (KR)
Agent: HONESTY & JR PARTNERS INTELLECTUAL PROPERTY LAW GROUP; 5F,615 Sunreung-ro, Gangnam-gu Seoul 135-833 (KR)
Priority Data:
10-2014-0181652 16.12.2014 KR
10-2015-0000781 05.01.2015 KR
10-2015-0048106 06.04.2015 KR
10-2015-0108672 31.07.2015 KR
Title (EN) MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME
(FR) TAURINE MODIFIÉE, ET COMPOSITION PHARMACEUTIQUE DESTINÉE À PRÉVENIR OU À TRAITER DES MALADIES MÉTABOLIQUES LA CONTENANT
(KO) 변성 타우린 및 이를 포함하는 대사질환 예방 또는 치료용 약학조성물
Abstract: front page image
(EN)The present invention relates to modified taurine, and a pharmaceutical composition or food composition, containing the same as an active ingredient, for preventing or treating metabolic diseases. More specifically, the modified taurine of the present invention, which has different physical features from the existing taurine, has a remarkable effect of preventing and treating metabolic syndromes, including an antithrombotic effect.
(FR)Cette invention concerne une taurine modifiée, et une composition pharmaceutique ou une composition alimentaire la contenant à titre de principe actif destinée à prévenir ou à traiter des maladies métaboliques. Plus spécifiquement, la taurine modifiée selon l'invention, qui présente des caractéristiques physiques différentes de la taurine existante, a un effet remarquable de prévention et de traitement des syndromes métaboliques, y compris un effet anti-thrombotique.
(KO)본 발명은 변성 타우린, 및 이를 유효성분으로 포함하는 대사질환 예방 또는 치료용 약학조성물 또는 식품조성물에 관한 것으로, 더욱 상세하게는 기존의 타우린과 상이한 물리적 성격을 갖는 본원 발명의 변성 타우린을 통하여 항혈전 효과를 포함하는 대사증후군의 예방 및 치료에 현저한 효과가 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)